Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CHC Healthcare GroupTPE:4164 +0.19%76 5-Year Yield-on-Cost % is 3.23 as of Aug. 03, 2026, which is 3% below its 10-year median of 3.33. GuruFocus rates TPE:4164 with a GF Score™ of 76/100 and a GF Value™ of NT$52.32 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 69 Medical Distribution companies, CHC Healthcare Group ranks worse than 50.72% on this metric.
CHC Healthcare Group's yield on cost for the quarter that ended in Mar. 2026 was 3.23.
The historical rank and industry rank for CHC Healthcare Group's 5-Year Yield-on-Cost % or its related term are showing as below:
TPE:4164'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.67 Med: 3.33 Max: 5.8
Current: 3.23
During the past 13 years, CHC Healthcare Group's highest Yield on Cost was 5.80. The lowest was 1.67. And the median was 3.33.
TPE:4164's 5-Year Yield-on-Cost % is ranked worse than 50.72% of 69
companies
in the Medical Distribution industry
Industry Median: 3.23
vs TPE:4164: 3.23
CHC Healthcare Group (TPE:4164) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
CHC Healthcare Group 5-Year Yield-on-Cost % Related Terms
TPE:4164 vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, CHC Healthcare Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's 5-Year Yield-on-Cost % falls into.
CHC Healthcare Group 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
CHC Healthcare Group (TPE:4164) has a 5-Year Yield-on-Cost % of 3.23 as of Aug. 03, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CHC Healthcare Group and its competitors. This is near median its historical median of 3.33. Over the past decade, CHC Healthcare Group's 5-Year Yield-on-Cost % has ranged from 1.67 to 5.80. According to the industry distribution chart, CHC Healthcare Group ranks #35 out of 69 companies in the Medical Distribution industry, placing it in the top 50.7%.
Is CHC Healthcare Group's 5-Year Yield-on-Cost % too high?
CHC Healthcare Group's current 5-Year Yield-on-Cost % of 3.23 is near median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 5.80. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.23. CHC Healthcare Group's value of 3.23 is 0% at this industry median. Based on the distribution chart, CHC Healthcare Group ranks #35 out of 69 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, CHC Healthcare Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CHC Healthcare Group ranks #35 out of 69 companies for 5-Year Yield-on-Cost %. This places CHC Healthcare Group in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.23. CHC Healthcare Group's value of 3.23 is 0% at this benchmark. Historically, CHC Healthcare Group's own 5-Year Yield-on-Cost % has ranged from 1.67 to 5.80 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 3.23, CHC Healthcare Group has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.23, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CHC Healthcare Group's current 5-Year Yield-on-Cost % of 3.23 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CHC Healthcare Group and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current 5-Year Yield-on-Cost % is 3.23, which is near median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$52.32, compared to a current price of NT$26.05 — trading 50.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.23, which is near median its 10-year median of 3.33 and 0% at the Medical Distribution industry median of 3.23. CHC Healthcare Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current 5-Year Yield-on-Cost % is 3.23 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 50.2% below its estimated GF Value™ of NT$52.32.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
5-Year Yield-on-Cost %: 3.23 (near median its 10-year median of 3.33)
GF Value™: NT$52.32 vs. price of NT$26.05 (50.2% below fair value)
Industry Position: 0% at the Medical Distribution median (#35 of 69)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
76GF Score
Get the complete analysis for TPE:4164
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
